Get Sample Pages - Poland Healthcare Market Size, Trends & Forecast 2026-2032

Poland Healthcare Market Research Report: Growth Drivers & Forecast (2026-2032)

By Healthcare Expenditure Type (Public Healthcare Expenditure, Private Healthcare Expenditure, Out-of-Pocket Expenditure), By Pharmaceutical Segment (Prescription Drugs, Over-the-C......ounter (OTC) Drugs, Generic Drugs, Branded Drugs, Biologics & Biosimilars), By Therapeutic Area (Cardiovascular Diseases, Oncology, Diabetes, Respiratory Diseases, Neurology, Infectious Diseases, Others), By Medical Device Type (Diagnostic Imaging Devices, Patient Monitoring Devices, Surgical Equipment, In-vitro Diagnostics, Orthopedic Devices, Cardiovascular Devices, Others), By Technology Type (Artificial Intelligence in Healthcare, Telemedicine & Remote Monitoring, Electronic Health Records (EHR), Healthcare Analytics, Robotic Surgery, Wearables & Health Apps), By Healthcare Workforce (Physicians, Nurses, Dentists, Allied Health Professionals), By Insurance Type (Public Health Insurance, Private Health Insurance), By Disease Category (Chronic Diseases, Infectious Diseases, Mental Health Disorders), By End User (Hospitals, Clinics, Diagnostic Centers / Laboratories, Ambulatory Surgical Centers, Home Healthcare, Research Institutes, Pharmacies, Others) Read more

Healthcare
Mar 2026
Pages 160
Report Format: PDF, Excel, PPT

Poland Healthcare Market Report Key Takeaways:

The Poland Healthcare Market size was valued at USD 62.5 billion in 2025 and is projected to grow from USD 68.75 billion in 2026 to USD 110.73 billion by 2032, exhibiting a CAGR of 8.27% during the forecast period.
About 38% of the total patients in Poland’s healthcare system are affected by cardiovascular diseases, highlighting their significant prevalence.
Cancer is another common condition, affecting around 25% of the total patients in Poland’s healthcare system in 2026.
Poland’s healthcare infrastructure includes around 888 general hospitals with nearly 160,000 hospital beds, along with more than 27,000 outpatient healthcare providers such as clinics, doctor practices, and dental practices, supported by a wide network of long-term care, rehabilitation, and residential medical facilities across the country.

Market Insights & Analysis: Poland Healthcare Market (2026-32):

The Poland Healthcare Market size was valued at USD 62.5 billion in 2025 and is projected to grow from USD 68.75 billion in 2026 to USD 110.73 billion by 2032, exhibiting a CAGR of 8.27% during the forecast period. i.e., 2026-32.

Poland’s healthcare sector has demonstrated a sustained growth trajectory supported by comprehensive public funding and broad population health coverage. Data from recent reports states that the country maintained 894 general hospitals with 161,207 total beds , reflecting a diversified network of inpatient care facilities that has gradually adjusted since past years. That year also saw an increasing trend in both outpatient consultations and patient admissions per capita, evidencing expanding service utilization across disease profiles. Poland’s hospital infrastructure remains a core foundation for care delivery to a population showing rising demands for complex and chronic disease management.

Digital technologies and innovation are increasingly influencing market dynamics, with healthcare IT platforms and AI integration shaping future growth pathways. National digital health infrastructures, including e-prescription and patient digital records platforms used by millions, now form the backbone of care coordination and data-driven planning. Digital transformation has accelerated in Polish healthcare: about 13.2 % of hospitals were using AI-based systems in 2024, more than double the share from the prior year, with applications concentrated in imaging diagnostics (CT/MRI). Additionally, around 16.2 % of medical facilities apply AI to clinical decision-making tasks, reflecting growing adoption for efficiency gains and improved diagnostic accuracy.

Epidemiological patterns in Poland indicate evolving demand drivers linked to demographic ageing and disease prevalence. Recent national clinical statistics show a significant share of patients seeking care for non‑communicable diseases such as cardiovascular disorders, oncological conditions, and metabolic syndromes, which are prevalent among older cohorts and exert sustained pressure on service capacity. Advanced diagnostic needs further give rise to growth in imaging and specialized pathology services, while long‑term care facilities are expanding to absorb rising chronic disease management volumes. Plan for Rare Diseases 2024–2025 allocates resources to expand expert centers, improve genomic diagnostics funding, and establish a national register to track such conditions. These efforts aim to enhance the detection and management of complex genetic and rare disorders.

Government policy frameworks and institutional reforms are actively supporting sector expansion and performance outcomes. Recent national health reforms enacted in 2025 provide new legal structures for hospital networks to transition services toward planned and recovery-oriented care models, enabling strategic institutional consolidation. These reforms link funding mechanisms with performance objectives across regions, while programs promoting coordinated primary care aim to strengthen service delivery across priority areas such as cardiology and endocrinology. Such policy actions, combined with sizable national recovery funds allocated to healthcare transformation, underpin a robust regulatory environment that will sustain market demand through 2032.

Poland Healthcare Market Scope:

Category	Segments
By Healthcare Expenditure Type	(Public Healthcare Expenditure, Private Healthcare Expenditure, Out-of-Pocket Expenditure),
By Pharmaceutical Segment	(Prescription Drugs, Over-the-Counter (OTC) Drugs, Generic Drugs, Branded Drugs, Biologics & Biosimilars),
By Therapeutic Area	(Cardiovascular Diseases, Oncology, Diabetes, Respiratory Diseases, Neurology, Infectious Diseases, Others),
By Medical Device Type	(Diagnostic Imaging Devices, Patient Monitoring Devices, Surgical Equipment, In-vitro Diagnostics, Orthopedic Devices, Cardiovascular Devices, Others),
By Technology Type	(Artificial Intelligence in Healthcare, Telemedicine & Remote Monitoring, Electronic Health Records (EHR), Healthcare Analytics, Robotic Surgery, Wearables & Health Apps),
By Healthcare Workforce	(Physicians, Nurses, Dentists, Allied Health Professionals),
By Insurance Type	(Public Health Insurance, Private Health Insurance),
By Disease Category	(Chronic Diseases, Infectious Diseases, Mental Health Disorders),
By End User	(Hospitals, Clinics, Diagnostic Centers / Laboratories, Ambulatory Surgical Centers, Home Healthcare, Research Institutes, Pharmacies, Others)

Poland Healthcare Market Driver:

Expansion of Public Healthcare Financing and Structural Investment Programs

The most influential driver accelerating growth in Poland’s healthcare sector is the sustained expansion of public healthcare financing supported by statutory spending reforms. Under legislation introduced by the Polish government, national health expenditure is required to reach 7% by 2027, strengthening long-term funding commitments for hospitals, diagnostics, and medical infrastructure. According to the OECD and Poland’s Ministry of Health, healthcare spending already exceeded USD 50 billion in 2024, reflecting continuous increases in allocations through the National Health Fund. This structural financing expansion has intensified in recent years as policymakers aim to address demographic ageing and rising chronic disease prevalence.

Higher public funding has translated directly into measurable increases in healthcare service utilization and infrastructure capacity across the country. Statistics Poland reported that more than 7 million patients were treated in general hospitals in 2023, while outpatient consultations exceeded 350 million visits, demonstrating the scale of demand supported by publicly financed care. Increased reimbursement for diagnostic services, oncology treatment pathways, and specialized care has stimulated greater service provision across both regional hospitals and tertiary institutions. Approximately USD 2.3 billion is allocated to modernise hospitals, including oncology and cardiac networks. Around USD 1.1 billion is dedicated to digital transformation, AI tools, and electronic medical record systems in hospitals.

Government-led investment programs further amplify this demand expansion by modernizing healthcare facilities and strengthening clinical capacity nationwide. Through the National Recovery and Resilience Plan, Poland has allocated billions of dollars for hospital modernization, digital health infrastructure, and advanced diagnostic equipment upgrades between 2025 and 2027. About USD 770 million has been awarded to hospitals to implement AI tools, digitise medical records, and expand healthcare IT systems .

These investments target improvements in surgical capacity, oncology treatment networks, and digital patient management platforms used by institutional healthcare providers. As a result, sustained public financing not only strengthens healthcare access but also generates continuous demand for healthcare services, technologies, and pharmaceutical products, reinforcing long-term market expansion through 2032.

Introduction
Executive Summary
1. Key Insights
2. Key Findings (2020–2024)
3. Market Outlook Snapshot (2025–2032F)
4. Strategic Imperatives
Macro Environment Analysis
1. Poland at a Glance
  1. Geographic Overview
  2. Political Structure
  3. Trade & Regional Alliances
  4. Others
2. Demographic Profile (2020–2032F)
  1. Population Trends
  2. Age Structure
  3. Urban vs Rural Distribution
  4. Fertility Rate Trends
  5. Migration Trends
  6. Ethnic Composition
3. Economic Profile (2020–2032F)
  1. GDP (Current & Constant USD)
  2. GDP by Sector
  3. Working Population & Labor Participation
  4. Per Capita Income & Purchasing Power
  5. Unemployment & Underemployment
  6. Inflation Rate & Healthcare Cost Impact
  7. Foreign Direct Investment Trends
4. Country PESTLE Analysis
Poland Healthcare Sector Analysis, 2026
1. Healthcare System Overview
  1. Structure of Healthcare System
  2. Public vs Private Healthcare
  3. Governance & Regulatory Authorities
  4. Others
2. Healthcare Ecosystem & Infrastructure (2020–2026)
  1. Healthcare Expenditure
    1. Healthcare Expenditure as % of GDP
    2. Per Capita Healthcare Expenditure
  2. Healthcare Facilities
    1. Number of Hospitals
    2. Number of Clinics
    3. Number of Pharmacies
    4. Number of Diagnostic Centres
    5. Public vs Private Distribution
    6. Bed Availability & Utilization
      1. Beds per 1,000 Population
      2. Beds Speciality
      3. Regional Disparities
  3. Healthcare Workforce
    1. Physicians per 1,000 Population
    2. Physicians by Speciality
    3. Nurses
    4. Dentists
    5. Allied Health Professionals
Health Outcomes & Public Health Indicators (2020–2026)
1. Life Expectancy (Male vs Female)
2. Infant Mortality Rate
3. Maternal Mortality Ratio
4. Immunisation Coverage Rates (Measles, DPT, HPV, COVID-19)
5. Overall Disease Burden Trends
Healthcare Reforms & Large-Scale Projects (2020-2026)
1. Government Reforms
2. Public-Private Partnerships
3. Infrastructure Expansion Projects
4. Private Sector Investments
5. Others
Insurance Framework
1. Public Health Insurance Programs
2. Private Health Insurance Market
3. Insurance Penetration & Coverage Gaps
4. Payer Landscape
5. Reimbursement Models (FFS, Bundled, Value-Based Care)
6. Claims Management & Transparency Issues
7. Out-of-Pocket Expenditure Trends (2020-2026)
Regulatory Environment (Healthcare Sector)
1. Market Authorisation for Pharmaceuticals
2. Market Authorisation for Medical Devices
3. Licensing for Manufacturing, Import & Export
4. Clinical Trial Regulations
5. Intellectual Property & Patent Protection
6. Advertising, Labeling & Packaging Regulations
7. Pharmacy & Hospital Licensing Rules
8. Others
Market Dynamics & Technology
1. Healthcare Market Dynamics
  1. Growth Drivers
  2. Challenges & Barriers
  3. Emerging Opportunities
  4. Value Chain Analysis
2. Healthcare Technology Trends
  1. Digital Health Maturity
  2. Telemedicine & Remote Monitoring
  3. Artificial Intelligence & Machine Learning
  4. Health Apps & Wearables
  5. Robotic Surgery
  6. EHR, Data Interoperability & Cybersecurity
  7. Others
Epidemiology Profile (By Age & By Gender) (2020–2032F)
1. Chronic Diseases
  1. Cardiovascular Diseases
    1. Prevalence
    2. Incidence
    3. Mortality Rate
    4. Risk Factors
    5. Healthcare & Economic Burden
    6. Infrastructure Challenges
    7. Treatment Landscape
    8. Others
  2. Diabetes
    1. Prevalence
    2. Incidence
    3. Mortality Rate
    4. Risk Factors
    5. Healthcare & Economic Burden
    6. Infrastructure Challenges
    7. Treatment Landscape
    8. Others
  3. Cancer
    1. Prevalence
    2. Incidence
    3. Mortality Rate
    4. Risk Factors
    5. Healthcare & Economic Burden
    6. Infrastructure Challenges
    7. Treatment Landscape
    8. Others
  4. Chronic Respiratory Diseases
    1. Prevalence
    2. Incidence
    3. Mortality Rate
    4. Risk Factors
    5. Healthcare & Economic Burden
    6. Infrastructure Challenges
    7. Treatment Landscape
    8. Others
  5. Chronic Kidney Disease
    1. Prevalence
    2. Incidence
    3. Mortality Rate
    4. Risk Factors
    5. Healthcare & Economic Burden
    6. Infrastructure Challenges
    7. Treatment Landscape
    8. Others
2. Infectious Diseases
  1. Tuberculosis
    1. Prevalence
    2. Incidence
    3. Mortality Rate
    4. Risk Factors
    5. Healthcare & Economic Burden
    6. Infrastructure Challenges
    7. Treatment Landscape
    8. Others
  2. HIV
    1. Prevalence
    2. Incidence
    3. Mortality Rate
    4. Risk Factors
    5. Healthcare & Economic Burden
    6. Infrastructure Challenges
    7. Treatment Landscape
    8. Others
  3. Hepatitis
    1. Prevalence
    2. Incidence
    3. Mortality Rate
    4. Risk Factors
    5. Healthcare & Economic Burden
    6. Infrastructure Challenges
    7. Treatment Landscape
    8. Others
  4. Others
3. Mental Health
  1. Prevalence of Mental Health Disorders
  2. Suicide Rates & Trends
  3. Urban-Rural & Gender Disparities
  4. Infrastructure Gaps
  5. Economic & Social Burden
Poland Healthcare System Stakeholders Analysis, 2026
1. Poland Pharmaceutical Market Outlook (2020–2030F)
  1. Market Size & Growth
    1. Market Size (USD Million), 2020-2030F
    2. Market by Key Segments
      1. Prescription vs OTC
      2. Generics vs Branded
      3. Therapeutic Category Distribution
  2. Manufacturing Landscape
  3. Distribution & Supply Chain
    1. Major Distributors
    2. Major Suppliers
  4. Major Local and Multinational Players
    1. Fresenius SE & Co. KGaA
    2. Helios Kliniken GmbH
    3. Asklepios Kliniken
    4. Sana Kliniken AG
    5. Rhön-Klinikum AG
    6. Siemens Healthineers
    7. Schön Klinik SE
    8. Klinikum Stuttgart
    9. University Medical Centre Hamburg
    10. Charité – Universitätsmedizin
  5. Pharmaceutical sector (Top 5–10 companies, % market share)
  6. Imports & Exports (Value in USD Million) (2020-2026)
  7. Key Pharmaceutical Clusters (if there)
  8. Investments and R&D (2020-2026)
  9. Others
2. Poland Medical Devices Market Outlook (2020–2030F)
  1. Market Size & Growth
    1. Market Size (USD Million), 2020-2030F
    2. Market by Key Segments
      1. By Device Type
      2. By Risk Class
      3. By End-User
  2. Manufacturing Landscape
  3. Distribution & Supply Chain
    1. Distributors
    2. Supply Chain
  4. Major Local and Multinational Players
    1. Fresenius SE & Co. KGaA
    2. Helios Kliniken GmbH
    3. Asklepios Kliniken
    4. Sana Kliniken AG
    5. Rhön-Klinikum AG
    6. Siemens Healthineers
    7. Schön Klinik SE
    8. Klinikum Stuttgart
    9. University Medical Centre Hamburg
    10. Charité – Universitätsmedizin
  5. Medical Devices Sector (Top 5–10 companies, % market share)
  6. Imports & Exports (Value in USD Million) (2020-2026)
  7. Key Medical Device Clusters (if there)
  8. Investments and R&D (2020-2026)
  9. Others
Poland Strategic & Investments in Healthcare Outlook (2025-2032F)
1. High-Growth Segments
2. Foreign Investment Opportunities
3. Government Incentives & Ease of Doing Business
4. Risk Assessment & Mitigation
Trade Associations & Industry Bodies
1. Pharmaceutical Associations
2. Medical Device Associations
3. Healthcare Provider Associations
4. Regulatory & Standards Bodies
Healthcare Trade Fairs & Conferences (2024–2026)
1. National Healthcare Exhibitions
2. Medical Technology Events
3. Pharmaceutical Conferences
4. Regional Latin America Events Relevant to Poland
Impact of Global Health Events
1. COVID-19 Impact (2020–2022)
2. Post-Pandemic Recovery
3. Emergency Preparedness Evolution
Strategic Recommendations
1. Market Entry Strategy
2. Partnership Models
3. Pricing Strategy
4. Regulatory Navigation
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *